Hind WH et al. |
Endocannabinoids modulate human blood-brain barrier permeability in vitro. |
2015 |
Br. J. Pharmacol. |
pmid:25651941
|
Monteleone AM et al. |
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa. |
2015 |
Am. J. Clin. Nutr. |
pmid:25646322
|
Scotchie JG et al. |
Endocannabinoid regulation in human endometrium across the menstrual cycle. |
2015 |
Reprod Sci |
pmid:24819878
|
Ford GK et al. |
Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats. |
2015 |
Eur J Pain |
pmid:25504741
|
Sticht MA et al. |
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats. |
2015 |
Neuroscience |
pmid:25499318
|
Rapino C et al. |
Endocannabinoids as biomarkers of human reproduction. |
2014 Jul-Aug |
Hum. Reprod. Update |
pmid:24516083
|
Thieme U et al. |
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24424856
|
Battista N et al. |
Analytical approaches for the determination of phytocannabinoids and endocannabinoids in human matrices. |
2014 Jan-Feb |
Drug Test Anal |
pmid:24218186
|
Ravi J et al. |
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. |
2014 |
Oncotarget |
pmid:24811863
|
Hama AT et al. |
Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain. |
2014 |
PLoS ONE |
pmid:24788435
|
Al Kury LT et al. |
Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. |
2014 |
Br. J. Pharmacol. |
pmid:24758718
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Kaczocha M et al. |
Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. |
2014 |
PLoS ONE |
pmid:24705380
|
Sun LJ et al. |
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. |
2014 |
Int. J. Infect. Dis. |
pmid:24704332
|
Jackson AR et al. |
Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction. |
2014 |
PLoS ONE |
pmid:24699635
|
Pertwee RG |
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. |
2014 |
Proc Nutr Soc |
pmid:24135210
|
Chianese R et al. |
Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testis. |
2014 |
Gen. Comp. Endocrinol. |
pmid:24566122
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Jackson AR et al. |
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. |
2014 |
J. Leukoc. Biol. |
pmid:24319288
|
Okura D et al. |
The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes. |
2014 |
Anesth. Analg. |
pmid:24557103
|